Celermajer D S, Bull C, Till J A, Cullen S, Vassillikos V P, Sullivan I D, Allan L, Nihoyannopoulos P, Somerville J, Deanfield J E
Cardiothoracic Unit, Hospital for Sick Children, London, England.
J Am Coll Cardiol. 1994 Jan;23(1):170-6. doi: 10.1016/0735-1097(94)90516-9.
This study was conducted to investigate the presentation and outcome of patients with Ebstein's anomaly of the tricuspid valve.
Ebstin's anomaly may present at any age and has a highly variable clinical course. Previous natural history studies have been based on clinical and angiographic diagnosis and have included mainly older children and adults. Echocardiography, however, has facilitated fetal and neonatal diagnosis so that the natural history needs to be redefined.
We reviewed 220 cases of Ebstein's anomaly presenting from fetal to adult life between 1958 and 1991, with 1 to 34 years of follow-up.
The most common presentation in each age group was abnormal routine prenatal scan for fetuses (86%), cyanosis for neonates (74%), heart failure for infants (43%), incidental murmur for children (63%) and arrhythmia for adolescents and adults (42%). Early presentation was frequently associated with other cardiac lesions, usually pulmonary stenosis or atresia. Surgery was undertaken at some stage in 86 (39%) of the 220 patients. Actuarial survival for all liveborn patients was 67% at 1 year and 59% at 10 years. There were 58 deaths, including 26 from heart failure, 19 perioperative and 8 sudden. Predictors of death included echocardiographic grade of severity at presentation (relative risk 2.7 for each increase in grade, 95% confidence limits 1.6 to 4.6), fetal presentation (6.9, confidence limits 1.6 to 16.5) and right ventricular outflow tract obstruction (2.1, confidence limits 1.1 to 4.4). Morbidity was mainly related to arrhythmias and late hemodynamic deterioration. Of 155 survivors, 129 (83%) were in functional class 1 and 104 (67%) were receiving no medical therapy.
In Ebstein's anomaly, fetal and neonatal presentation is associated with a poor outcome and can be predicted by the echocardiographic appearance and presence of associated lesions. In older children and adults, incidental findings and arrhythmia are common and the long-term outcome is superior.
本研究旨在调查三尖瓣埃布斯坦畸形患者的临床表现及预后。
埃布斯坦畸形可在任何年龄出现,临床病程高度多变。既往的自然史研究基于临床和血管造影诊断,主要纳入年龄较大的儿童和成人。然而,超声心动图技术推动了胎儿及新生儿期的诊断,因此有必要重新定义其自然史。
我们回顾了1958年至1991年间从胎儿期至成年期出现的220例埃布斯坦畸形病例,并进行了1至34年的随访。
各年龄组最常见的表现为:胎儿期常规产前扫描异常(86%)、新生儿期发绀(74%)、婴儿期心力衰竭(43%)、儿童期偶然发现杂音(63%)以及青少年和成年期心律失常(42%)。早期表现常与其他心脏病变相关,通常为肺动脉狭窄或闭锁。220例患者中有86例(39%)在某个阶段接受了手术。所有存活患者1年时的精算生存率为67%,10年时为59%。共有58例死亡,其中26例死于心力衰竭,19例死于围手术期,8例猝死。死亡的预测因素包括就诊时超声心动图严重程度分级(每增加一级相对风险为2.7,95%置信区间为1.6至4.6)、胎儿期表现(6.9,置信区间为1.6至16.5)以及右心室流出道梗阻(2.1,置信区间为1.1至4.4)。发病主要与心律失常和晚期血流动力学恶化有关。在155名幸存者中,129例(83%)心功能为1级,104例(67%)未接受药物治疗。
在埃布斯坦畸形中,胎儿期和新生儿期的表现与不良预后相关,可通过超声心动图表现及相关病变的存在来预测。在年龄较大的儿童和成人中,偶然发现和心律失常较为常见,长期预后较好。